Prognostic Factors for COVID-19 Hospitalized Patients with Preexisting Type 2 Diabetes

Figure 1

Study design. A total of 382 hospitalized COVID-19 patients (108 with and 274 without T2D) were included in this study. In comparing the clinical factors between COVID-19 patients in the diabetes and nondiabetes groups and between survivors and nonsurvivors, clinical factors specifically associated with disease outcomes were used to perform univariate and multivariate Cox regression models. Based on the independent factors identified by Cox models, a nomogram was built for individualized survival prediction and validated by discrimination and calibration.